Optogenetic inhibition of Gα signalling alters and regulates circuit functionality and early circuit formation

preprint OA: closed
📄 Open PDF View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Researchers developed PiGM-Iq, an optogenetic tool that inhibits Gαq signaling, altering neuronal circuit formation and function in model organisms and vertebrate embryos.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Optogenetic techniques provide genetically targeted, spatially and temporally precise approaches to correlate cellular activities and physiological outcomes. In the nervous system, G-protein-coupled receptors (GPCRs) have essential neuromodulatory functions through binding extracellular ligands to induce intracellular signaling cascades. In this work, we develop and validate a new optogenetic tool that disrupt Gα q signaling through membrane recruitment of a minimal Regulator of G-protein signaling (RGS) domain. This approach, P hoto- i nduced M odulation of G α protein – I nhibition of Gα q (PiGM-Iq), exhibited potent and selective inhibition of Gα q signaling. We alter the behavior of C. elegans and Drosophila with outcomes consistent with GPCR-Gα q disruption. PiGM-Iq also changes axon guidance in culture dorsal root ganglia neurons in response to serotonin. PiGM-Iq activation leads to developmental deficits in zebrafish embryos and larvae resulting in altered neuronal wiring and behavior. By altering the choice of minimal RGS domain, we also show that this approach is amenable to Gα i signaling.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00